AGN
- NYSE - DRUGS - Drug Manufacturers - Other
Allergan Inc
|
$161.54 |
-2.16 -1.32%
|
$164.00
|
$174.49
|
-7.42% |
2,249,322 80.82%
|
2,783,000
|
Most Recent Note for AGN - 8/5/2014 11:50:31 AM
Slumped below its 50 DMA line with a streak of 4 consecutive losses. Consolidating in a tight range since a gap up gain on 4/22/14 following an unsolicited bid from Valeant Pharmaceuticals (VRX). Reported earnings +24% on +17% sales revenues for the Jun '14 quarter. Prior mid-day reports cautioned members - "Its annual earnings growth has been steady. Quarterly earnings comparisons have been below the +25% guideline."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
AKRX
- NASDAQ - DRUGS - Drug Manufacturers - Other
Akorn Inc
|
$35.94 |
+1.61
4.69%
|
$37.55
|
$37.08
|
-3.07% |
1,128,518 113.99%
|
990,000
|
Most Recent Note for AKRX - 8/5/2014 11:51:17 AM
Gapped up today hitting a new 52-week high. Reported earnings +23% on +23% sales revenues for the Mar '14 quarter and prior quarterly earnings increases were sub par. Found support at its 200 DMA line during its deep consolidation since noted with caution in the 2/27/14 mid-day report - "Annual earnings history (A criteria) is not a match with the models of past great winners identified using the fact-based investment system.'"
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CAR
- NASDAQ - Leisure-Services
Avis Budget Group Inc
|
$60.82 |
+2.70
4.64%
|
$61.18
|
$61.95
|
-1.83% |
1,299,161 102.62%
|
1,266,000
|
Most Recent Note for CAR - 8/5/2014 11:52:43 AM
Gapped up today rebounding above its 50 DMA line and rallying toward its 52-week high. Prior mid-day reports cautioned members - "Quarterly and annual earnings history has been erratic and not a match with the fundamental guidelines (C and A criteria) of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CNI
- NYSE - TRANSPORTATION - Railroads
Canadian Natl Ry Co
|
$66.10 |
-0.76 -1.13%
|
$66.67
|
$69.75
|
-5.24% |
562,323 65.92%
|
853,000
|
Most Recent Note for CNI - 8/5/2014 11:53:51 AM
Consolidating above its 50 DMA line. Quarterly and annual earnings history has not been strong and steady. This Canadian railroad operator was dropped from the Featured Stocks list on 7/21/2006.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVS
- NYSE - RETAIL - Drug Stores
C V S Caremark Corp
|
$77.56 |
+0.19
0.25%
|
$78.96
|
$79.43
|
-2.35% |
2,471,244 71.03%
|
3,479,000
|
Most Recent Note for CVS - 8/5/2014 11:54:43 AM
Perched near its 52-week and all-time highs, forming an orderly base and finding support near its 50 DMA line. Fundamental concerns remain while its Mar '14 quarterly earnings were +23% on +6% sales revenues versus the year ago period. It survived but failed to impress since long ago noted in the 5/06/08 mid-day report -"Earnings growth below guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IBCA
- NASDAQ - BANKING - Regional - Northeast Banks
Intervest Bancshares
|
$9.41 |
+0.02
0.21%
|
$9.43
|
$9.60
|
-1.98% |
353,089 246.92%
|
143,000
|
Most Recent Note for IBCA - 8/5/2014 11:55:25 AM
Holding its ground at its 52-week high following a considerable gap up and volume-driven gain on 8/01/14 news it is to be acquired by Bank of the Ozarks Inc (OZRK). Fundamentals are not a match with the C and A criteria of the fact-based investment system.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IFF
- NYSE - CHEMICALS - Specialty Chemicals
Intl Flavors & Fragrance
|
$98.07 |
-3.86 -3.79%
|
$98.94
|
$105.84
|
-7.34% |
369,548 106.19%
|
348,000
|
Most Recent Note for IFF - 8/5/2014 11:57:21 AM
Violated its 50 DMA line with damaging volume-driven losses last week. Fundamental concerns remain. Noted with caution in prior mid-day reports - "Sales revenues and earnings history is below the guidelines of the fact-based system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
IHG
- NYSE - LEISURE - Lodging
Intercontinental Hotels
|
$38.62 |
-1.40 -3.50%
|
$38.62
|
$42.54
|
-9.21% |
190,222 58.71%
|
324,000
|
Most Recent Note for IHG - 8/5/2014 11:59:31 AM
Slumped below its 50 DMA line last week. Mar and Jun '14 sales and earnings were below the year ago periods. Noted with caution in prior mid-day reports - " Reported earnings +18% on +0% sales revenues for the quarter ended Dec 31, 2013 versus the year ago period. Its prior earnings history (A criteria) is below guidelines of the fact-based system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
JLL
- NYSE - REAL ESTATE - Property Management/Developmen
Jones Lang Lasalle Inc
|
$130.93 |
+1.33
1.03%
|
$131.00
|
$131.70
|
-0.58% |
126,166 60.08%
|
210,000
|
Most Recent Note for JLL - 8/5/2014 12:00:51 PM
Found support at its 50 DMA line and it is rallying near its 52-week high with today's 3rd consecutive volume-driven gain. The 8/01/14 mid-day report cautioned members - "Reported earnings +46% on +29% sales revenues for the Jun '14 quarter, but fundamental concerns remain. Prior quarterly earnings per share increases should be above the +25% minimum guideline (C criteria) in the most recent 3 or 4 quarterly comparisons versus the year ago periods. Research shows that earnings growth is the single most important indicator of a stock's potential to make a big price move."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NVO
- NYSE - DRUGS - Drug Manufacturers - Other
Novo Nordisk A/S Adr
|
$45.90 |
+0.51
1.12%
|
$46.13
|
$48.42
|
-5.20% |
2,274,029 274.64%
|
828,000
|
Most Recent Note for NVO - 8/5/2014 12:02:10 PM
Found support at its 50 DMA line this week, tallying volume-driven gains. Prior mid-day reports repeatedly cautioned members - "Reported earnings +18% on +9% sales revenues for the Mar '14 quarter, a 3rd consecutive quarterly comparison with earnings below the +25% guideline (C criteria). It has earned high ranks after demonstrating strong steady annual earnings (A criteria) growth. This Denmark-based Medical - Ethical Drug firm has seen the number of top-rated funds owning its shares fall from 216 in Jun '13 to 208 in Mar '14, not a good sign concerning the I criteria."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PTC
- NASDAQ - Computer Sftwr-Design
P T C Inc
|
$38.16 |
+1.54
4.21%
|
$38.34
|
$40.40
|
-5.54% |
675,315 64.44%
|
1,048,000
|
Most Recent Note for PTC - 8/5/2014 12:03:56 PM
Rebounding above its 50 DMA line with today's 3rd consecutive gain, rallying within striking distance of its 52-week high. Noted in prior mid-day reports with caution - "Fundamentals are not a match with the fact-based investment system (C criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PXD
- NYSE - ENERGY - Independent Oil & Gas
Pioneer Natural Resource
|
$213.85 |
-8.56 -3.85%
|
$219.86
|
$234.60
|
-8.84% |
925,907 76.58%
|
1,209,000
|
Most Recent Note for PXD - 8/5/2014 12:05:59 PM
Slumped below its 50 DMA line last week with damaging volume-driven losses. Reported earnings +31% on -18% sales revenues for the quarter ended June 30, 2014 versus the year ago period. Fundamental concerns remain. Found support near its 200 DMA line during its consolidation since noted with caution in the 11/06/13 mid-day report - "Prior quarterly and annual earnings (C and A criteria) history has been below the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
QLYS
- NASDAQ - Computer Sftwr-Security
Qualys Inc
|
$28.78 |
+3.44
13.56%
|
$28.78
|
$29.94
|
-3.89% |
160,458 116.27%
|
138,000
|
Most Recent Note for QLYS - 8/5/2014 12:08:28 PM
Rebounding from below its 50 DMA and 200 DMA lines, challenging its 52-week high with today's 2nd consecutive considerable volume-driven gain. Reported strong sales revenues and earnings increases in the Mar and Jun '14 quarterly comparisons, but fundamental concerns remain with respect to the C criteria.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SLCA
- NYSE - CHEMICALS - Specialty Chemicals
U S Silica Holdings Inc
|
$59.55 |
+0.35
0.59%
|
$60.58
|
$63.25
|
-5.85% |
1,000,746 73.69%
|
1,358,000
|
Most Recent Note for SLCA - 8/5/2014 12:11:09 PM
Perched within close striking distance of its 52-week high, finding support above its 50 DMA line. Earnings were above the +25% minimum guideline (C criteria) in Jun '14 quarterly comparison, but prior comparisons were sub par. Completed Secondary Offerings on 3/14/13, 6/06/13, 11/08/13, and 12/09/13. Since dropped from the Featured Stocks list on 4/03/13 it found support above its 200 DMA line during its consolidation then rallied to new highs.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VDSI
- NASDAQ - COMPUTER SOFTWARE & SERVICES - Security Software & Services
Vasco Data Security Intl
|
$14.28 |
+0.05
0.35%
|
$14.39
|
$14.36
|
-0.56% |
233,458 74.35%
|
314,000
|
Most Recent Note for VDSI - 8/5/2014 12:12:23 PM
Touched another new 52-week high today. Held its ground following a considerable gap up gain on 7/24/14. Prior mid-day report repeatedly cautioned members - "Reported earnings +200% on +28% sales revenues for the Jun '14 quarter and raised guidance. The 3 latest quarterly earnings reports have been above the +25% minimum earnings guideline (C criteria) but its prior quarterly and annual earnings (A criteria) history is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
XRS
- NYSE - Consumer Svcs-Education
T A L Education Gp A Ads
|
$31.12 |
-0.82 -2.57%
|
$31.91
|
$32.00
|
-2.75% |
426,116 67.32%
|
633,000
|
Most Recent Note for XRS - 8/5/2014 12:16:59 PM
This Chinese firm in the Consumer Services - Education industry group is perched at its 52-week high following a recent spurt of volume-driven gains. No resistance remains due to overhead supply. Reported strong earnings and sales increases for the May '14 quarter. Repeatedly noted with caution in prior mid-day reports - "Reported strong earnings increases above the +25% minimum guideline (C criteria) in Aug, Nov '13, and Feb '14 quarterly comparisons and sequential quarters showed encouraging acceleration in sales revenues increases. Downturn in FY '13 earnings is a flaw concerning its annual earnings history (A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ZBRA
- NASDAQ - COMPUTER HARDWARE - Computer Peripherals
Zebra Tech Corp Cl A
|
$78.59 |
-3.96 -4.80%
|
$80.82
|
$86.02
|
-8.64% |
852,846 177.31%
|
481,000
|
Most Recent Note for ZBRA - 8/5/2014 12:21:35 PM
Violated its 50 DMA line with today's volume-driven loss. Reported earnings +35% on +14% sales revenues for the Jun '14 quarter, its 3rd consecutive quarterly earnings increase above the +25% minimum guideline (C criteria). Annual earnings (A criteria) have been improving since a downturn in FY '08 and '09.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|